News

AstraZeneca released detailed data from the Phase III ADAURA clinical trial of Tagrisso (osimertinib) in early-stage epidermal growth factor receptor-mutated (EGFRm) non-small cell lung cancer, demonstrating what they call “unprecedented disease-free survival.” The company is presenting the study during...

The fully automated Swisslog ACPaQ palletizing solution has won the German Innovation Award 2020 in the “Machines & Engineering” category. This award compares existing solutions and awards outstanding achievements in innovation and honors solutions that distinguish themselves primarily by...

Thermo Fisher Scientific, the world leader in serving science, and MSAID GmbH, a software company transforming proteomics with deep learning, announce an exclusive license agreement to develop and commercialize deep learning tools for proteomics, making MSAID’s Prosit-derived framework widely...

A new generation, high resolution mass spectrometer (MS) is designed to give proteomics, metabolomics, biopharmaceutical characterization and small-molecule scientists the analytical performance required for research and high-throughput analyses. The new system will help drive discovery and identification with increased...

Leading pharmaceutical outsourcing partner, the Wasdell Group (Wasdell), has been granted an Investigational Medicinal Product (IMP) licence by the Health Products Regulatory Authority (HPRA) at its Dundalk, Ireland facility. This licence enables Wasdell to expand the facility’s services to include...

Truking is celebrating its 20th anniversary with the ground-breaking dig for a new construction project. The pharmaceutical machinery manufacturer is extending its industrial park in the central Chinese city of Changsha, where eight new buildings will go up within...

Albumedix Ltd. , the world leader in recombinant human albumin (rAlb), announced its succession plan as Peter Rosholm, after 13 years leading the company, has decided to step down as CEO and handover the company’s leadership. Peter’ successor as...